The Nobel Prize in medicine is awarded to Americans Victor Ambros and Gary Ruvkun for their discovery of microRNA, a fundamental principle governing how gene activity is regulated.
The Nobel Assembly says that their discovery is “proving to be fundamentally important for how organisms develop and function.”
Ambrose performed the research that led to his prize at Harvard University. He is currently a professor of natural science at the University of Massachusetts Medical School.
Ruvkun’s research was performed at Massachusetts General Hospital and the Harvard Medical School, where he’s a professor of genetics, says Thomas Perlmann, secretary-general of the Nobel Committee.
Both men were awarded Israel’s Wolf Prize in 2014. Ruvkun, who is Jewish, won the Dan David Prize, headquartered at Tel Aviv University, in 2011. He is married to art history professor Natasha Staller.
Olle Kaempe, member of the Nobel Assembly, speaks to the media in front of a screen displaying a picture of this year’s laureates Victor Ambros and Gary Ruvkun during the announcement of the winners of the 2024 Nobel Prize in Physiology or Medicine at the Karolinska Institute in Stockholm on October 7, 2024. (Jonathan NACKSTRAND / AFP)
The prize carries a cash award of 11 million Swedish kronor ($1 million) from a bequest left by the prize’s creator, Swedish inventor Alfred Nobel.
The announcement launched this year’s Nobel prizes award season.
Nobel announcements continue with the physics prize on Tuesday, chemistry on Wednesday and literature on Thursday. The Nobel Peace Prize will be announced Friday and the Nobel Memorial Prize in Economic Sciences on Oct. 14.
Bridging the US-Israel divide
While the heart of The Times of Israel’s work takes place in Israel, so many of Jerusalem’s actions are influenced by those in Washington’s halls of power.
As ToI’s US bureau chief, I work to gain access to decision-makers in the United States government so our readers can understand the US-Israel relationship beyond the platitudes evident in public statements.
I'm proud of our ability to inform without sensationalizing, our dedication to be fast while ensuring accuracy, and our determination to present Israel's entire, complex story.
Your support through The Times of Israel Community helps us continue to keep readers around the world properly informed about the critical Israel-US relationship. Do you appreciate our news coverage? If so, please join the ToI Community today.
- Jacob Magid, The Times of Israel's US bureau chief
Yes, I'll join
Yes, I'll join
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel eleven years ago - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this